InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

1.330 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about InMed Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

March 20, 2023

It's time to start off the trading week with a breakdown of the biggest pre-market stock movers for Monday and what's behind that movement!

Via InvestorPlace

Despite Global Economic Pressures, InMed Pharma's Accomplishments In 2022 Could Be A Catalyst For Further Growth In 2023 ↗

March 17, 2023

InMed Pharmaceuticals Inc. (NASDAQ: INM), a biopharmaceutical company that is dedicated to advancing research and therapies for a wide range of medical conditions, has reported that it has made some...

Via Benzinga

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Peer-Reviewed Study Results Published

March 13, 2023

Via Investor Brand Network

Rare Cannabinoids Could Help Treat Atopic Dermatitis, Psoriasis, Pruritus And Acne: New Study ↗

March 13, 2023

InMed Pharmaceuticals Inc. (NASDAQ: INM) announced that a peer-reviewed scientific study entitled "Rare phytocannabinoids exert anti-inflammatory effects on human keratinocytes via the endocannabinoid...

Via Benzinga

Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

March 10, 2023

Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO to Present at Two March Investor Events

March 07, 2023

Via Investor Brand Network

Life Sciences Virtual Investor Forum Agenda Announced for March 9th

March 07, 2023

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financial, Corporate Report

February 21, 2023

Via Investor Brand Network

InMed Pharmaceuticals Q2 FY23 Revenue Grows 77% YoY, What About Net Loss? ↗

February 21, 2023

InMed Pharmaceuticals Inc. (NASDAQ:INM) released financial results for the second quarter of fiscal year 2023 which ended December 31, 2022, revealing revenue of $469,783, a 77% increase compared to...

Via Benzinga

InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update

February 17, 2023

From InMed Pharmaceuticals Inc.

Via GlobeNewswire

InMed Submits Form 12b-25

February 09, 2023

From InMed Pharmaceuticals Inc.

Via GlobeNewswire

Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 20, 2023

Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 133.1% to $0.2870. Helbiz recently announced discontinuation of operations in non-profitable markets.

Via Benzinga

This Company's Rare Cannabinoids May Hold Promise In The Treatment Of Neurodegenerative Diseases Like Alzheimer's ↗

January 11, 2023

Neurodegenerative diseases such as Parkinson’s, Alzheimer's and others are increasing worldwide as the population ages.

Via Benzinga

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023 Business Outlook

January 10, 2023

Via CannabisNewsWire

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023 Business Outlook

January 10, 2023

Via Investor Brand Network

InMed Provides Business Update and Milestones for 2023

January 10, 2023

From InMed Pharmaceuticals Inc.

Via GlobeNewswire

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket ↗

January 06, 2023

Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 06, 2023

The final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday!

Via InvestorPlace

Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 05, 2023

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...

Via Benzinga

Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket ↗

January 05, 2023

Gainers Vyant Bio, Inc. (NASDAQ: VYNT) shares rose 110.4% to $1.62 in pre-market trading after the company said it has engaged LifeSci Capital as its advisor to explore strategic alternatives.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 05, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers for Thursday that traders need to know about!

Via InvestorPlace

Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 04, 2023

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive...

Via Benzinga

Why Oblong Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket ↗

January 04, 2023

Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares rose 63.2% to $0.4201 in pre-market trading after dropping 8% on Tuesday. Elys Game Technology and Cloakbook were recently granted a license to...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 04, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

Key Marijuana Executive Changes: Who Will Lead MariMed After CEO's Passing? MJBiz CEO Steps Down ↗

December 19, 2022

MJBiz CEO To Step Down Marijuana Business Daily's Chris Walsh will step down as CEO in January.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Shares Annual General Meeting Results

December 16, 2022

Via Investor Brand Network

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Shares Annual General Meeting Results

December 16, 2022

Via CannabisNewsWire

InMed Announces Results of 2022 Annual General Meeting

December 15, 2022

From InMed Pharmaceuticals Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.